Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Immunotherapy Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma

NCT05488366 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT05488366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05488366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Immunotherapy Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma
Lead sponsor
University of California, Irvine
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 3, 2022
Completion date
August 31, 2026
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue